Ingersoll Rand Reports Fourth Quarter and Full-Year 2025 Results
Well-positioned for strong operational performance in 2026
Fourth Quarter 2025 Highlights
(All comparisons against the fourth quarter of 2024 and results are as reported unless otherwise noted)
Strong performance driven by its competitive differentiator -
-
Orders of
$1,952 million , up 8% -
Revenues of
$2,091 million , up 10% -
Net income attributable to
Ingersoll Rand Inc. of$266 million ,$0.67 per share-
Adjusted net income attributable to
Ingersoll Rand Inc. 1 of$382 million ,$0.96 per share, up 14%
-
Adjusted net income attributable to
-
Adjusted EBITDA1 of
$580 million , up 9%, with a margin of 27.7% -
Operating cash flow of
$499 million and free cash flow1 of$462 million -
Liquidity of
$3.8 billion as ofDecember 31, 2025 , including$1.2 billion of cash on hand and undrawn capacity of$2.6 billion under available credit facilities
Full-Year 2025 Highlights
(All comparisons against 2024 and results are as reported unless otherwise noted)
-
Orders of
$7,716 million , up 9% -
Revenues of
$7,651 million , up 6% -
Net income attributable to
Ingersoll Rand Inc. of$581 million ,$1.45 per share-
Adjusted net income attributable to
Ingersoll Rand Inc. 1 of$1,341 million ,$3.34 per share, up 2%
-
Adjusted net income attributable to
-
Adjusted EBITDA1 of
$2,094 million , up 4%, with a margin of 27.4% -
Operating cash flow of
$1,356 million and free cash flow1 of$1,220 million -
Returned
$1,050 million of value to shareholders through share repurchases and dividends
2026 Guidance
-
Expect full-year 2026 revenue growth of 2.5% to 4.5% and Adjusted EBITDA1 of
$2,130 to$2,190 million , up 2% to 5% over prior year -
2026 Adjusted EPS1 expected to be in a range of
$3.45 to$3.57 , up 3% to 7% over prior year
“Against the backdrop of a complex global environment, we delivered strong growth, earnings, and free cash flow, reflecting the resilience and execution strength of our portfolio,” said
| ____________________________ | |
|
1 |
Non-GAAP measure (definitions and/or reconciliations in tables below). |
Fourth Quarter 2025 Segment Review
(All comparisons against the fourth quarter of 2024 and results are as reported unless otherwise noted.)
-
Orders
of
$1,550 million , up 9%, or up 1% organic -
Revenues
of
$1,672 million , up 11%, or up 3% organic2 -
Segment Adjusted EBITDA
of
$484 million , up 6% - Segment Adjusted EBITDA Margin of 28.9%, down 140 basis points
- IT&S delivered its fourth consecutive quarter of organic order growth finishing up 1% for both the fourth quarter and the full year. Adjusted EBITDA margin was down year over year driven primarily by the dilutive impact of tariffs and continued commercial investments for growth.
Precision and Science Technologies Segment (P&ST): Mission-critical precision liquid, gas, air, and powder handling technologies for life sciences and industrial applications as well as aerospace and defense applications
-
Orders
of
$402 million , up 7%, or up 1% organic -
Revenues
of
$419 million , up 8%, or up 4% organic2 -
Segment Adjusted EBITDA
of
$127 million , up 19% - Segment Adjusted EBITDA Margin of 30.4%, up 280 basis points
- P&ST saw organic order growth of 1% in the fourth quarter and 2% for the full year. Adjusted EBITDA margin finished at 30.4% and was up 280 basis points year over year driven by strong operational execution fueled by IRX.
Balance Sheet and Cash Flow
Consistent with our comprehensive capital allocation strategy led by M&A, in the fourth quarter
In
| ____________________________ | |
|
2 |
Non-GAAP measure (definitions and/or reconciliations in tables below). |
|
3 |
Calculated as Net Debt divided by LTM Adjusted EBITDA |
2026 Guidance2,4,5,6
|
Guidance Metric |
Full Year 2026 |
Full Year Assumptions* |
|
Revenue Growth4 |
2.5% to 4.5% |
|
|
Adjusted EBITDA2 |
|
|
|
Adjusted EPS2 |
+5% growth at the midpoint |
|
|
Free Cash Flow2 to Adj.
|
~95% |
|
|
*The phasing of Revenue, Adjusted EBITDA, and Adjusted EPS is consistent with prior years. |
||
Reconciliations of non-GAAP measures related to full-year 2026 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.
Conference Call
| ____________________________ | |
| 4 |
All revenue outlook commentary expressed in percentages and based on growth as compared to 2024. |
| 5 |
Based on |
| 6 |
Reflects all completed and closed M&A as of |
Forward-Looking Statements
This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to expectations of
These forward-looking statements are based on Ingersoll Rand’s current expectations and are subject to risks and uncertainties, which may cause actual results to differ materially from these current expectations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) adverse impact on our operations and financial performance due to geopolitical tensions, natural disaster, catastrophe, global pandemics, cyber events, or other events outside of our control; (2) unexpected costs, charges or expenses resulting from completed and proposed business combinations; (3) uncertainty of the expected financial performance of the Company; (4) failure to realize the anticipated benefits of completed and proposed business combinations; (5) the ability of the Company to implement its business strategy; (6) difficulties and delays in achieving revenue and cost synergies; (7) inability of the Company to retain and hire key personnel; (8) evolving legal, regulatory and tax regimes; (9) changes in general economic and/or industry specific conditions; (10) actions by third parties, including government agencies; and (11) other risk factors detailed in Ingersoll Rand’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”), as such factors may be updated from time to time in its periodic filings with the
Any forward-looking statements speak only as of the date of this release.
About
# # #
Non-
In addition to consolidated GAAP financial measures,
Management and Ingersoll Rand’s board of directors regularly use these measures as tools in evaluating the Company’s operating and financial performance and in establishing discretionary annual compensation. Such measures are provided in addition to, and should not be considered to be a substitute for, or superior to, the comparable measures under GAAP. In addition,
Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Net Income Attributable to
Reconciliations of Organic Revenue Growth/(Decline), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Net Income Attributable to
Reconciliations of non-GAAP measures related to full year 2026 guidance have not been provided due to the unreasonable efforts it would take to provide such reconciliations due to the high variability, complexity and uncertainty with respect to forecasting and quantifying certain amounts that are necessary for such reconciliations, including net income (loss) and adjustments that could be made for acquisitions-related expenses, restructuring and other business transformation costs, gains or losses on foreign currency exchange and the timing and magnitude of other amounts in the reconciliation of historic numbers. For the same reasons, we are unable to address the probable significance of the unavailable information, which could have a potentially unpredictable, and potentially significant, impact on our future GAAP financial results.
Due to rounding, numbers presented throughout this release may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures.
|
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited; in millions, except per share amounts)
|
|||||||||||||||
|
|
For the Three Month Period
|
|
For the Twelve Month Period
|
||||||||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Revenues |
$ |
2,091.2 |
|
|
$ |
1,898.6 |
|
|
$ |
7,650.9 |
|
|
$ |
7,235.0 |
|
|
Cost of sales |
|
1,200.5 |
|
|
|
1,083.2 |
|
|
|
4,314.6 |
|
|
|
4,065.0 |
|
|
Gross Profit |
|
890.7 |
|
|
|
815.4 |
|
|
|
3,336.3 |
|
|
|
3,170.0 |
|
|
Selling and administrative expenses |
|
357.1 |
|
|
|
331.7 |
|
|
|
1,439.3 |
|
|
|
1,344.4 |
|
|
Amortization of intangible assets |
|
109.7 |
|
|
|
95.2 |
|
|
|
387.5 |
|
|
|
373.0 |
|
|
Impairment of goodwill |
|
— |
|
|
|
— |
|
|
|
229.7 |
|
|
|
— |
|
|
Impairment of other intangible assets |
|
7.6 |
|
|
|
13.9 |
|
|
|
43.7 |
|
|
|
13.9 |
|
|
Other operating expense, net |
|
26.1 |
|
|
|
(4.2 |
) |
|
|
91.5 |
|
|
|
138.6 |
|
|
Operating Income |
|
390.2 |
|
|
|
378.8 |
|
|
|
1,144.6 |
|
|
|
1,300.1 |
|
|
Interest expense |
|
64.9 |
|
|
|
61.8 |
|
|
|
253.9 |
|
|
|
213.2 |
|
|
Loss on extinguishment of debt |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3.0 |
|
|
Other income, net |
|
(9.4 |
) |
|
|
(8.1 |
) |
|
|
(44.6 |
) |
|
|
(48.9 |
) |
|
Income Before Income Taxes |
|
334.7 |
|
|
|
325.1 |
|
|
|
935.3 |
|
|
|
1,132.8 |
|
|
Provision for income taxes |
|
66.3 |
|
|
|
88.2 |
|
|
|
219.4 |
|
|
|
262.5 |
|
|
Loss on equity method investments |
|
— |
|
|
|
(5.0 |
) |
|
|
(127.1 |
) |
|
|
(24.0 |
) |
|
Net Income |
|
268.4 |
|
|
|
231.9 |
|
|
|
588.8 |
|
|
|
846.3 |
|
|
Less: Net income attributable to noncontrolling interests |
|
2.3 |
|
|
|
2.1 |
|
|
|
7.4 |
|
|
|
7.7 |
|
|
Net Income Attributable to |
$ |
266.1 |
|
|
$ |
229.8 |
|
|
$ |
581.4 |
|
|
$ |
838.6 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Basic earnings per share |
|
0.68 |
|
|
|
0.57 |
|
|
|
1.46 |
|
|
|
2.08 |
|
|
Diluted earnings per share |
|
0.67 |
|
|
|
0.57 |
|
|
|
1.45 |
|
|
|
2.06 |
|
|
CONSOLIDATED BALANCE SHEETS (Unaudited; in millions, except share amounts)
|
|||||||
|
|
|
|
|
||||
|
Assets |
|
|
|
||||
|
Current assets: |
|
|
|
||||
|
Cash and cash equivalents |
$ |
1,248.8 |
|
|
$ |
1,541.2 |
|
|
Accounts receivable, net of allowance for credit losses of |
|
1,518.0 |
|
|
|
1,335.4 |
|
|
Inventories |
|
1,172.9 |
|
|
|
1,055.0 |
|
|
Other current assets |
|
308.3 |
|
|
|
231.9 |
|
|
Total current assets |
|
4,248.0 |
|
|
|
4,163.5 |
|
|
Property, plant and equipment, net of accumulated depreciation of |
|
930.3 |
|
|
|
842.1 |
|
|
|
|
8,484.1 |
|
|
|
8,148.1 |
|
|
Other intangible assets, net |
|
4,240.3 |
|
|
|
4,372.8 |
|
|
Deferred tax assets |
|
38.7 |
|
|
|
26.1 |
|
|
Other assets |
|
355.8 |
|
|
|
457.2 |
|
|
Total assets |
$ |
18,297.2 |
|
|
$ |
18,009.8 |
|
|
Liabilities and Stockholders’ Equity |
|
|
|
||||
|
Current liabilities: |
|
|
|
||||
|
Short-term borrowings and current maturities of long-term debt |
$ |
1.4 |
|
|
$ |
3.1 |
|
|
Accounts payable |
|
996.1 |
|
|
|
843.6 |
|
|
Accrued liabilities |
|
1,068.8 |
|
|
|
972.2 |
|
|
Total current liabilities |
|
2,066.3 |
|
|
|
1,818.9 |
|
|
Long-term debt, less current maturities |
|
4,783.3 |
|
|
|
4,754.4 |
|
|
Pensions and other postretirement benefits |
|
134.2 |
|
|
|
139.3 |
|
|
Deferred income tax liabilities |
|
696.9 |
|
|
|
757.6 |
|
|
Other liabilities |
|
462.5 |
|
|
|
294.3 |
|
|
Total liabilities |
$ |
8,143.2 |
|
|
$ |
7,764.5 |
|
|
Stockholders’ equity: |
|
|
|
||||
|
Common stock, |
|
4.3 |
|
|
|
4.3 |
|
|
Capital in excess of par value |
|
9,699.9 |
|
|
|
9,633.6 |
|
|
Retained earnings |
|
3,053.1 |
|
|
|
2,503.5 |
|
|
Accumulated other comprehensive loss |
|
(148.3 |
) |
|
|
(468.5 |
) |
|
|
|
(2,519.2 |
) |
|
|
(1,493.9 |
) |
|
Total |
$ |
10,089.8 |
|
|
$ |
10,179.0 |
|
|
Noncontrolling interests |
|
64.2 |
|
|
|
66.3 |
|
|
Total stockholders’ equity |
$ |
10,154.0 |
|
|
$ |
10,245.3 |
|
|
Total liabilities and stockholders’ equity |
$ |
18,297.2 |
|
|
$ |
18,009.8 |
|
|
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited; in millions)
|
|||||||
|
|
Twelve Month Period Ended |
||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
Cash Flows From Operating Activities: |
|
|
|||||
|
Net income |
$ |
588.8 |
|
|
$ |
846.3 |
|
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
||||
|
Amortization of intangible assets |
|
387.5 |
|
|
|
373.0 |
|
|
Depreciation |
|
118.3 |
|
|
|
109.0 |
|
|
Impairment of goodwill and other intangible assets |
|
273.4 |
|
|
|
13.9 |
|
|
Non-cash restructuring charges |
|
— |
|
|
|
1.6 |
|
|
Stock-based compensation expense |
|
53.0 |
|
|
|
58.8 |
|
|
Loss on equity method investments |
|
127.1 |
|
|
|
24.0 |
|
|
Foreign currency transaction losses, net |
|
18.6 |
|
|
|
3.2 |
|
|
Non-cash adjustments to carrying value of LIFO inventories |
|
17.8 |
|
|
|
6.7 |
|
|
Loss on extinguishment of debt |
|
— |
|
|
|
3.0 |
|
|
Loss on sale of asbestos-related assets and liabilities |
|
— |
|
|
|
33.7 |
|
|
Deferred income taxes |
|
(79.4 |
) |
|
|
(33.1 |
) |
|
Other non-cash adjustments |
|
9.9 |
|
|
|
7.7 |
|
|
Changes in assets and liabilities: |
|
|
|
||||
|
Receivables |
|
(59.1 |
) |
|
|
(45.1 |
) |
|
Inventories |
|
(26.1 |
) |
|
|
39.8 |
|
|
Accounts payable |
|
78.7 |
|
|
|
13.3 |
|
|
Accrued liabilities |
|
(35.3 |
) |
|
|
(34.5 |
) |
|
Other assets and liabilities, net |
|
(117.5 |
) |
|
|
(24.6 |
) |
|
Net cash provided by operating activities |
|
1,355.7 |
|
|
|
1,396.7 |
|
|
Cash Flows From Investing Activities: |
|
|
|
||||
|
Capital expenditures |
|
(135.6 |
) |
|
|
(149.1 |
) |
|
Net cash paid in acquisitions |
|
(525.0 |
) |
|
|
(2,958.7 |
) |
|
Disposals of property, plant and equipment |
|
— |
|
|
|
6.1 |
|
|
Other investing |
|
— |
|
|
|
(6.0 |
) |
|
Net cash used in investing activities |
|
(660.6 |
) |
|
|
(3,107.7 |
) |
|
Cash Flows From Financing Activities: |
|
|
|
||||
|
Principal payments on long-term debt |
|
— |
|
|
|
(1,242.7 |
) |
|
Proceeds from long-term debt |
|
— |
|
|
|
3,296.9 |
|
|
Purchases of treasury stock |
|
(1,018.0 |
) |
|
|
(260.7 |
) |
|
Cash dividends on common stock |
|
(31.8 |
) |
|
|
(32.3 |
) |
|
Proceeds from stock option exercises |
|
15.3 |
|
|
|
32.2 |
|
|
Payments to settle cross-currency swaps |
|
— |
|
|
|
(19.9 |
) |
|
Payments of deferred and contingent acquisition consideration |
|
(8.0 |
) |
|
|
(23.4 |
) |
|
Payments of debt issuance costs |
|
— |
|
|
|
(32.3 |
) |
|
Other financing |
|
(11.3 |
) |
|
|
(10.3 |
) |
|
Net cash provided by (used in) financing activities |
|
(1,053.8 |
) |
|
|
1,707.5 |
|
|
Effect of exchange rate changes on cash and cash equivalents |
|
66.3 |
|
|
|
(50.8 |
) |
|
Net decrease in cash and cash equivalents |
|
(292.4 |
) |
|
|
(54.3 |
) |
|
Cash and cash equivalents, beginning of year |
|
1,541.2 |
|
|
|
1,595.5 |
|
|
Cash and cash equivalents, end of year |
$ |
1,248.8 |
|
|
$ |
1,541.2 |
|
|
UNAUDITED ADJUSTED FINANCIAL INFORMATION (Dollars in millions)
|
|||||||||||||||
|
|
For the Three Months
Ended |
|
For the Twelve Months
Ended |
||||||||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Revenues |
$ |
2,091.2 |
|
|
$ |
1,898.6 |
|
|
$ |
7,650.9 |
|
|
$ |
7,235.0 |
|
|
Adjusted EBITDA |
$ |
580.1 |
|
|
$ |
532.3 |
|
|
$ |
2,093.8 |
|
|
$ |
2,018.1 |
|
|
Adjusted EBITDA Margin |
|
27.7 |
% |
|
|
28.0 |
% |
|
|
27.4 |
% |
|
|
27.9 |
% |
|
Free Cash Flow |
$ |
461.5 |
|
|
$ |
490.9 |
|
|
$ |
1,220.1 |
|
|
$ |
1,247.6 |
|
|
Free Cash Flow Margin |
|
22.1 |
% |
|
|
25.9 |
% |
|
|
15.9 |
% |
|
|
17.2 |
% |
|
RECONCILIATION OF NET INCOME TO ADJUSTED NET INCOME ATTRIBUTABLE TO
(Unaudited; in millions)
|
|||||||||||||||
|
|
For the Three Months
|
|
For the Twelve Months
|
||||||||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Net Income |
$ |
268.4 |
|
|
$ |
231.9 |
|
|
$ |
588.8 |
|
|
$ |
846.3 |
|
|
Plus: |
|
|
|
|
|
|
|
||||||||
|
Provision for income taxes |
|
66.3 |
|
|
|
88.2 |
|
|
|
219.4 |
|
|
|
262.5 |
|
|
Amortization of acquisition related intangible assets |
|
107.0 |
|
|
|
93.0 |
|
|
|
377.4 |
|
|
|
364.3 |
|
|
Impairment of goodwill and other intangible assets |
|
7.6 |
|
|
|
13.9 |
|
|
|
273.4 |
|
|
|
13.9 |
|
|
Restructuring and related business transformation costs |
|
23.0 |
|
|
|
8.0 |
|
|
|
51.7 |
|
|
|
32.3 |
|
|
Acquisition and other transaction related expenses and non-cash charges |
|
4.0 |
|
|
|
0.3 |
|
|
|
26.0 |
|
|
|
59.8 |
|
|
Stock-based compensation |
|
7.2 |
|
|
|
15.2 |
|
|
|
53.0 |
|
|
|
58.8 |
|
|
Foreign currency transaction losses (gains), net |
|
3.0 |
|
|
|
(6.0 |
) |
|
|
18.6 |
|
|
|
3.2 |
|
|
Loss on equity method investments |
|
— |
|
|
|
5.0 |
|
|
|
127.1 |
|
|
|
24.0 |
|
|
Loss on extinguishment of debt |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3.0 |
|
|
Adjustments to LIFO inventories |
|
2.3 |
|
|
|
(0.5 |
) |
|
|
17.8 |
|
|
|
6.7 |
|
|
Cybersecurity incident costs |
|
— |
|
|
|
— |
|
|
|
(1.3 |
) |
|
|
0.5 |
|
|
Loss on asbestos sale |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
58.8 |
|
|
Other adjustments |
|
(1.2 |
) |
|
|
(0.6 |
) |
|
|
(5.9 |
) |
|
|
0.4 |
|
|
Minus: |
|
|
|
|
|
|
|
||||||||
|
Income tax provision, as adjusted |
|
103.5 |
|
|
|
104.8 |
|
|
|
397.9 |
|
|
|
385.2 |
|
|
Adjusted Net Income |
|
384.1 |
|
|
|
343.6 |
|
|
|
1,348.1 |
|
|
|
1,349.3 |
|
|
Less: Net income attributable to noncontrolling interest |
|
2.3 |
|
|
|
2.1 |
|
|
|
7.4 |
|
|
|
7.7 |
|
|
Adjusted Net Income Attributable to |
$ |
381.8 |
|
|
$ |
341.5 |
|
|
$ |
1,340.7 |
|
|
$ |
1,341.6 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Adjusted Basic Earnings Per Share1 |
$ |
0.97 |
|
|
$ |
0.85 |
|
|
$ |
3.37 |
|
|
$ |
3.33 |
|
|
Adjusted Diluted Earnings Per Share2 |
$ |
0.96 |
|
|
$ |
0.84 |
|
|
$ |
3.34 |
|
|
$ |
3.29 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Average shares outstanding: |
|
|
|
|
|
|
|
||||||||
|
Basic, as reported |
|
393.0 |
|
|
|
403.0 |
|
|
|
398.1 |
|
|
|
403.4 |
|
|
Diluted, as reported |
|
395.8 |
|
|
|
406.6 |
|
|
|
401.0 |
|
|
|
407.2 |
|
|
Adjusted diluted2 |
|
395.8 |
|
|
|
406.6 |
|
|
|
401.0 |
|
|
|
407.2 |
|
|
1 Basic and diluted earnings per share (as reported) are calculated by dividing net income attributable to |
|
2 Adjusted diluted share count and adjusted diluted earnings per share include incremental dilutive shares, using the treasury stock method, which are added to average shares outstanding. |
|
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA AND ADJUSTED NET INCOME AND CASH FLOWS FROM OPERATING ACTIVITIES TO FREE CASH FLOW (Unaudited; in millions)
|
|||||||||||||||
|
|
For the Three Month Period
|
|
For the Twelve Month Period
|
||||||||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Net Income |
$ |
268.4 |
|
|
$ |
231.9 |
|
|
$ |
588.8 |
|
|
$ |
846.3 |
|
|
Plus: |
|
|
|
|
|
|
|
||||||||
|
Interest expense |
|
64.9 |
|
|
|
61.8 |
|
|
|
253.9 |
|
|
|
213.2 |
|
|
Provision for income taxes |
|
66.3 |
|
|
|
88.2 |
|
|
|
219.4 |
|
|
|
262.5 |
|
|
Depreciation expense |
|
30.4 |
|
|
|
27.5 |
|
|
|
113.8 |
|
|
|
105.0 |
|
|
Amortization expense |
|
109.7 |
|
|
|
95.2 |
|
|
|
387.5 |
|
|
|
373.0 |
|
|
Impairment of goodwill and other intangible assets |
|
7.6 |
|
|
|
13.9 |
|
|
|
273.4 |
|
|
|
13.9 |
|
|
Restructuring and related business transformation costs |
|
23.0 |
|
|
|
8.0 |
|
|
|
51.7 |
|
|
|
32.3 |
|
|
Acquisition and other transaction related expenses and non-cash charges |
|
4.0 |
|
|
|
0.3 |
|
|
|
26.0 |
|
|
|
59.8 |
|
|
Stock-based compensation |
|
7.2 |
|
|
|
15.2 |
|
|
|
53.0 |
|
|
|
58.8 |
|
|
Foreign currency transaction losses (gains), net |
|
3.0 |
|
|
|
(6.0 |
) |
|
|
18.6 |
|
|
|
3.2 |
|
|
Loss on equity method investments |
|
— |
|
|
|
5.0 |
|
|
|
127.1 |
|
|
|
24.0 |
|
|
Loss on extinguishment of debt |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3.0 |
|
|
Adjustments to LIFO inventories |
|
2.3 |
|
|
|
(0.5 |
) |
|
|
17.8 |
|
|
|
6.7 |
|
|
Cybersecurity incident costs |
|
— |
|
|
|
— |
|
|
|
(1.3 |
) |
|
|
0.5 |
|
|
Loss on asbestos sale |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
58.8 |
|
|
Interest income on cash and cash equivalents |
|
(5.5 |
) |
|
|
(7.6 |
) |
|
|
(30.0 |
) |
|
|
(43.3 |
) |
|
Other adjustments |
|
(1.2 |
) |
|
|
(0.6 |
) |
|
|
(5.9 |
) |
|
|
0.4 |
|
|
Adjusted EBITDA |
$ |
580.1 |
|
|
$ |
532.3 |
|
|
$ |
2,093.8 |
|
|
$ |
2,018.1 |
|
|
Minus: |
|
|
|
|
|
|
|
||||||||
|
Interest expense |
|
64.9 |
|
|
|
61.8 |
|
|
|
253.9 |
|
|
|
213.2 |
|
|
Income tax provision, as adjusted |
|
103.5 |
|
|
|
104.8 |
|
|
|
397.9 |
|
|
|
385.2 |
|
|
Depreciation expense |
|
30.4 |
|
|
|
27.5 |
|
|
|
113.8 |
|
|
|
105.0 |
|
|
Amortization of non-acquisition related intangible assets |
|
2.7 |
|
|
|
2.2 |
|
|
|
10.1 |
|
|
|
8.7 |
|
|
Interest income on cash and cash equivalents |
|
(5.5 |
) |
|
|
(7.6 |
) |
|
|
(30.0 |
) |
|
|
(43.3 |
) |
|
Adjusted Net Income |
$ |
384.1 |
|
|
$ |
343.6 |
|
|
$ |
1,348.1 |
|
|
$ |
1,349.3 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Free Cash Flow: |
|
|
|
|
|
|
|
||||||||
|
Cash flows from operating activities |
|
499.0 |
|
|
|
526.2 |
|
|
|
1,355.7 |
|
|
|
1,396.7 |
|
|
Minus: |
|
|
|
|
|
|
|
||||||||
|
Capital expenditures |
|
37.5 |
|
|
|
35.3 |
|
|
|
135.6 |
|
|
|
149.1 |
|
|
Free Cash Flow |
$ |
461.5 |
|
|
$ |
490.9 |
|
|
$ |
1,220.1 |
|
|
$ |
1,247.6 |
|
|
RECONCILIATION OF SEGMENT ADJUSTED EBITDA TO NET INCOME (Unaudited; in millions)
|
|||||||||||||||
|
|
For the Three Months
|
|
For the Twelve Months
|
||||||||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Orders |
|
|
|
|
|
|
|
||||||||
|
|
$ |
1,549.5 |
|
|
$ |
1,422.2 |
|
|
$ |
6,119.6 |
|
|
$ |
5,706.6 |
|
|
Precision and Science Technologies |
|
402.2 |
|
|
|
377.8 |
|
|
|
1,596.3 |
|
|
|
1,398.9 |
|
|
Total Orders |
$ |
1,951.7 |
|
|
$ |
1,800.0 |
|
|
$ |
7,715.9 |
|
|
$ |
7,105.5 |
|
|
Revenue |
|
|
|
|
|
|
|
||||||||
|
|
$ |
1,672.2 |
|
|
$ |
1,511.0 |
|
|
$ |
6,056.4 |
|
|
$ |
5,818.1 |
|
|
Precision and Science Technologies |
|
419.0 |
|
|
|
387.6 |
|
|
|
1,594.5 |
|
|
|
1,416.9 |
|
|
Total Revenue |
$ |
2,091.2 |
|
|
$ |
1,898.6 |
|
|
$ |
7,650.9 |
|
|
$ |
7,235.0 |
|
|
Segment Adjusted EBITDA |
|
|
|
|
|
|
|
||||||||
|
|
$ |
484.1 |
|
|
$ |
457.6 |
|
|
$ |
1,747.9 |
|
|
$ |
1,754.8 |
|
|
Precision and Science Technologies |
|
127.4 |
|
|
|
106.8 |
|
|
|
478.0 |
|
|
|
418.8 |
|
|
Total Segment Adjusted EBITDA |
$ |
611.5 |
|
|
$ |
564.4 |
|
|
$ |
2,225.9 |
|
|
$ |
2,173.6 |
|
|
Less items to reconcile Segment Adjusted EBITDA to Income Before Income Taxes: |
|
|
|
|
|
|
|
||||||||
|
Corporate expenses not allocated to segments |
$ |
31.4 |
|
|
$ |
32.1 |
|
|
$ |
132.1 |
|
|
$ |
155.5 |
|
|
Interest expense |
|
64.9 |
|
|
|
61.8 |
|
|
|
253.9 |
|
|
|
213.2 |
|
|
Depreciation and amortization expense |
|
140.1 |
|
|
|
122.7 |
|
|
|
501.3 |
|
|
|
478.0 |
|
|
Impairment of goodwill and other intangible assets |
|
7.6 |
|
|
|
13.9 |
|
|
|
273.4 |
|
|
|
13.9 |
|
|
Restructuring and related business transformation costs |
|
23.0 |
|
|
|
8.0 |
|
|
|
51.7 |
|
|
|
32.3 |
|
|
Acquisition and other transaction related expenses and non-cash charges |
|
4.0 |
|
|
|
0.3 |
|
|
|
26.0 |
|
|
|
59.8 |
|
|
Stock-based compensation |
|
7.2 |
|
|
|
15.2 |
|
|
|
53.0 |
|
|
|
58.8 |
|
|
Foreign currency transaction losses (gains), net |
|
3.0 |
|
|
|
(6.0 |
) |
|
|
18.6 |
|
|
|
3.2 |
|
|
Loss on extinguishment of debt |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3.0 |
|
|
Adjustments to LIFO inventories |
|
2.3 |
|
|
|
(0.5 |
) |
|
|
17.8 |
|
|
|
6.7 |
|
|
Cybersecurity incident costs |
|
— |
|
|
|
— |
|
|
|
(1.3 |
) |
|
|
0.5 |
|
|
Loss on asbestos sale |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
58.8 |
|
|
Interest income on cash and cash equivalents |
|
(5.5 |
) |
|
|
(7.6 |
) |
|
|
(30.0 |
) |
|
|
(43.3 |
) |
|
Other adjustments |
|
(1.2 |
) |
|
|
(0.6 |
) |
|
|
(5.9 |
) |
|
|
0.4 |
|
|
Income Before Income Taxes |
|
334.7 |
|
|
|
325.1 |
|
|
|
935.3 |
|
|
|
1,132.8 |
|
|
Provision for income taxes |
|
66.3 |
|
|
|
88.2 |
|
|
|
219.4 |
|
|
|
262.5 |
|
|
Loss on equity method investments |
|
— |
|
|
|
(5.0 |
) |
|
|
(127.1 |
) |
|
|
(24.0 |
) |
|
Net Income |
$ |
268.4 |
|
|
$ |
231.9 |
|
|
$ |
588.8 |
|
|
$ |
846.3 |
|
|
ORDERS AND REVENUE GROWTH BY SEGMENT(1)
|
|||||
|
(Unaudited) |
Three Month Period Ended
|
||||
|
|
Orders |
|
Revenue |
||
|
|
|
|
|
||
|
Organic growth |
1.1 |
% |
|
2.9 |
% |
|
Impact of foreign currency |
3.0 |
% |
|
3.3 |
% |
|
Impact of acquisitions |
4.4 |
% |
|
4.0 |
% |
|
Total orders and revenue growth |
8.5 |
% |
|
10.2 |
% |
|
|
|
|
|
||
|
Industrial |
|
|
|
||
|
Organic growth |
1.0 |
% |
|
2.7 |
% |
|
Impact of foreign currency |
2.9 |
% |
|
3.3 |
% |
|
Impact of acquisitions |
5.0 |
% |
|
4.7 |
% |
|
Total orders and revenue growth |
8.9 |
% |
|
10.7 |
% |
|
|
|
|
|
||
|
Precision & Science Technologies |
|
|
|
||
|
Organic growth |
1.4 |
% |
|
3.7 |
% |
|
Impact of foreign currency |
3.3 |
% |
|
3.1 |
% |
|
Impact of acquisitions |
1.8 |
% |
|
1.3 |
% |
|
Total orders and revenue growth |
6.5 |
% |
|
8.1 |
% |
|
(1) |
Organic revenue growth, impact of foreign currency, and impact of acquisitions are non-GAAP measures. References to “impact of acquisitions” refer to GAAP sales from acquired businesses recorded prior to the first anniversary of the acquisition. The portion of GAAP revenue attributable to currency translation is calculated as the difference between (a) the period-to-period change in revenue (excluding acquisition sales) and (b) the period-to-period change in revenue (excluding acquisition sales) after applying prior year foreign exchange rates to the current year period. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260212160722/en/
Investor Relations:
Matthew.Fort@irco.com
Media:
Sara.Hassell@irco.com
Source: